M
MiMedx Group, Inc.
MDXG · NASDAQ · Healthcare · 622M
Closing price
$4.67
+1.08% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
14.2×
Price / net assetsP/B
2.7×
Enterprise value / EBITDAEV/EBITDA
6.6×
Free cash flow yieldFCF yield
10.6%
Return on equityROE
18.9%
Operating margin
15.3%
Net debt / EBITDAbalance-sheet strength
-1.7×
Interest coverage
35.8×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.